EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL

This adverse event was reported 133 times

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 1 0.0019
1 RIBOCICLIB 55 0.0017
2 PILOCARPINE HYDROCHLORIDE 4 0.0016
3 DACOMITINIB 1 0.0013
4 FULVESTRANT 18 0.0005
5 LETROZOLE TABLETS 22 0.0004
6 LETROZOLE 25 0.0004
7 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 8 0.0003
8 ZOLEDRONIC ACID 13 0.0003
9 IBANDRONATE SODIUM 1 0.0003
See all drugs enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL

EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Receptor Antagonist [EPC] 18 0.0004
1 Aromatase Inhibitor [EPC] 26 0.0002
2 Provitamin D2 Compound [EPC] 4 0.0001
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 13 0.0001
4 Calcineurin Inhibitor Immunosuppressant [EPC] 16 0.0001
5 Calcium [EPC] 15 0.0001
6 Expectorant [EPC] 18 0.0001
7 CD20-directed Cytolytic Antibody [EPC] 16 0.0001
8 Bile Acid [EPC] 1 0.0000
9 Microtubule Inhibitor [EPC] 7 0.0000
See all drug classes enriched for association with EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL